The 2005 International Stroke Conference, New Orleans, Louisiana, February 2-4, 2005.
Zahuranec
Darin B
DB
Department of Neurology, University of Michigan Health System, Ann Arbor, MI, USA.
D000925:Anticoagulants / Q000627:therapeutic use; D002545:Brain Ischemia / Q000188:drug therapy; D002543:Cerebral Hemorrhage / Q000188:drug therapy; D005167:Factor VII / Q000627:therapeutic use; D015942:Factor VIIa; D006801:Humans; D010960:Plasminogen Activators / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D020521:Stroke / Q000150:complications / Q000517:prevention & control
D000925:Anticoagulants; D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D010960:Plasminogen Activators; D015942:Factor VIIa